SMMT   $18.99  3.09% Market Closed After Close 18.96 -0.16%

Summit Therapeutics Inc
Total Cash 486.90M
totalCashPerShare 0.66
EBITDA -181.49M
Total Debt 32.50M
quickRatio 8.262
currentRatio 8.309
Total Revenue
debtToEquity 7.421
Revenue/Share
ROA -0.31467
ROE -0.7321
grossProfits
freeCashflow -62.82M
operatingCashflow -112.89M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 14.58B
forwardPE -51.526318
floatShares 105.06M
sharesOutstanding 737.45M
sharesShort 15.45M
sharesShortPriorMonth 20.73M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.84%
heldPercentInstitutions 0.10%
Short Ratio help_outline 2.68%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 0.594
Price To Book help_outline 32.96
earningsQuarterlyGrowth
netIncomeToCommon -196.68M
trailingEps -0.23%
forwardEps -0.38%
enterpriseToEbitda -80.35
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.08 4Q 2024
institutionsCount 189
lastUpdated Nov. 6, 2024, 6:29 p.m.